Longevity science

A new drug designed to prevent the early stages of Alzheimer’s disease could enter clinical trials in a few years’  time, according to scientists.

Alzheimer’s disease begins when a protein called amyloid-β (Aβ) starts to clump together in senile plaques in the brain, damaging nerve cells and leading to memory loss and confusion.